Zurueck zur Suche

Reporte zur Charge U6265AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OK 2 WA 2 CA 2 PA 2 NC 2 NJ 1 UT 1 OR 1 NE 1 NY 1 OH 1

VAERS 2639447

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
17.11.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Good afternoon Our MA gave an expired Td Wrong or expired product- VFC TD single dose 0.5 mL, vaccine -expired XX/XX/2021 Lot # U6265AA Manufacture - Sanofi Pasteur

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1456717

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
OK
Alter
-
Geschlecht
F
Eingang
08.07.2021
Impfdatum
30.06.2021
Beginn
30.06.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient was administed an expired dose of TENIVAC, no AE; Initial information regarding an unsolicited valid non-serious case was received from other health care professional via Agency (Reference number- 00663918) and transmitted to Sanofi on 30-Jun-2021. This case involves a 58 year old female patient who was administered an expired dose (0.5ml) of the suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (lot number: U6265AA; expiry date: 19-Apr-2021; form: solution for injection) via unknown route in the right deltoid for prophylactic vaccination on 30-Jun-2021 (expired product administered). Medical history, medical treatment(s), past vaccination(s), concomitant medications and family history were not provided. It was a case of an actual medication error due to expired vaccine used (latency same day). The reporter wanted information as to repeat the vaccination or not. At the time of report, no adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1446048

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
WA
Alter
73,0
Geschlecht
F
Eingang
03.07.2021
Impfdatum
28.06.2021
Beginn
28.06.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

A patient was administered expired vaccine, no AE; Initial information regarding an unsolicited valid non-serious case was received from other healthcare professional via Medical Information (Reference number- 00659835) and transmitted to Sanofi on 28-Jun-2021. This case involves a 73-year-old female patient who received 0.5 mL of expired dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (lot U6265AA and expiry date: 19-Apr-2021) via an intramuscular route in the left arm for prophylactic vaccination on 28-Jun-2021 (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided. It was reported that "Caller would like to know if this dose is considered a valid dose or whether the dose needs to be repeated." This was a case of actual medication error due to expired vaccine used (latency same day). At time of reporting, no adverse events were reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1394152

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
NJ
Alter
75,0
Geschlecht
F
Eingang
12.06.2021
Impfdatum
24.05.2021
Beginn
24.05.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

medical assistant had administered an expired vaccine to patient with no reported adverse event; Initial information regarding an unsolicited valid non-serious case was received from a other health care professional via Medical Information (Reference number- 00628493) and transmitted to Sanofi on 04-Jun-2021. This case involves a 75 years old female patient who received 0.5 ml of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (lot U6265AA, expiry date: 19-Apr-2021) via intramuscular route in unknown administration site for prophylactic vaccination on 24-May-2021 (Expired product administered) Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. It was a case of an actual medication error due to Expired vaccine used (latency same day) At the time of report, no adverse event was reported. Caller stated a medical assistance accidentally administered the diphtheria tetanus (TD) vaccine. Caller asked if there is anything they need to do, were there any adverse effects and what were the next steps This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1373936

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
UT
Alter
-
Geschlecht
U
Eingang
04.06.2021
Impfdatum
18.05.2021
Beginn
18.05.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient inadvertently administered expired Tenivac vaccine/ NO AE; Initial information regarding an unsolicited valid non-serious case was received from a other healthcare professional via Agency (Reference number- 00610121) and transmitted to Sanofi on 20-May-2021. This case involves a patient (unknown demographics) who received inadvertently administered expired vaccine DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (batch number: U6265AA and expiry date: 19-Apr-2021 via unknown route at an unknown administration site) (expired product administered) on 18-May-2021 for prophylactic vaccination. The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided. It was an actual medication error case due to expired vaccine used (latency: same day). Reporter want to know what need to know and which actions to take for the affected donors At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1340539

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
OR
Alter
-
Geschlecht
M
Eingang
22.05.2021
Impfdatum
07.05.2021
Beginn
07.05.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error

Symptomtext

14 year old patient was given an expired TENIVAC, no AE; Initial information regarding an unsolicited valid non-serious case was received from other healthcare professional via agency (Reference number- 00592731) and transmitted to Sanofi on 07-May-2021. This case involves a 14 year old male patient who was administered 0.5 ml dose of expired suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (lot number: U6265AA; expiry date: 19-APR-2021) via unknown route in the left deltoid for prophylactic vaccination on 07-MAY-2021 (expired product administered). Medical history, medical treatment(s), past vaccination(s), concomitant medications and family history were not provided. It was a case of an actual medication error due to expired vaccine used (latency same day). At the time of report, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1327342

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
OK
Alter
14,0
Geschlecht
F
Eingang
18.05.2021
Impfdatum
21.04.2021
Beginn
21.04.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Pt. received Tenivac on 4/21/21 that expired on 4/19/21. Parent was contacted by voicemail and letter. Awaiting response to schedule a repeat dose. No known adverse events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None disclosed on immunization worksheet.
Vorgeschichte
None disclosed on immunization worksheet.
Andere Medikamente
None disclosed on immunization worksheet
Allergien
None disclosed on immunization worksheet.
Vorherige Impfungen
-

VAERS 1322611

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
CA
Alter
7,0
Geschlecht
M
Eingang
17.05.2021
Impfdatum
20.04.2021
Beginn
20.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error

Symptomtext

patient received expired dose of TENIVAC/no AE; Initial information received on 21-Apr-2021 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 7 year-old male patient who was vaccinated with expired dose of DIPHTHERIA-2/TETANUS-5 TOXOIDS WITH PRESERVATIVE [TENIVAC] (expired product administered). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included POLIO VACCINE INACT 3V (VERO) (IPOL POLIO VACCINE); MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD); INFLUENZA VACCINE INACT SPLIT 3V (FLULAVAL); HEPATITIS B VACCINE RHBSAG (YEAST) (ENGERIX-B) and HEPATITIS A VACCINE INACT (HAVRIX) for prophylactic vaccination. On 20-Apr-2021, the patient received a first dose 0.5 mL of suspect DIPHTHERIA-2/TETANUS-5 TOXOIDS WITH PRESERVATIVE (strength: standard; lot U6265AA and expiry date 19-Apr-2021) via an intramuscular route in the right arm for prophylactic vaccination. It was a case of an actual medication error due to expired vaccine used (latency was on same day). At the time of report, no adverse event reported. Result of assessment was not reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
IPOL POLIO VACCINE; PROQUAD; FLULAVAL; ENGERIX-B; HAVRIX
Allergien
-
Vorherige Impfungen
-

VAERS 1309636

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
12.05.2021
Impfdatum
20.04.2021
Beginn
20.04.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error Product administered to patient of inappropriate age

Symptomtext

Patient received expired Tenivac vaccine with no AE; Initial information received on 21-Apr-2021 regarding an unsolicited valid non-serious case from physician. This case involves a 7-year-old male patient who received expired 0.5 mL dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] [lot U6265AA, expiry date: not reported] via an intramuscular route in the right arm for prophylactic vaccination on 20-Apr-2021 [expired product administered]. Medical history, medical treatment, vaccination and family history were not provided. Concomitant medications included POLIO VACCINE INACT 3V (VERO) (IPOL [POLIO VACCINE INACT 3V (VERO)]); MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3), VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (PROQUAD); INFLUENZA VACCINE INACT SPLIT 3V (FLULAVAL); HEPATITIS B VACCINE RHBSAG (YEAST) (ENGERIX-B); and HEPATITIS A VACCINE INACT (HAVRIX). It was also a case of actual mediation error due to expired vaccine used administered (latency: on the same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
IPOL [POLIO VACCINE INACT 3V (VERO)]; PROQUAD; FLULAVAL; ENGERIX-B; HAVRIX
Allergien
-
Vorherige Impfungen
-

VAERS 1306238

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
PA
Alter
56,0
Geschlecht
F
Eingang
11.05.2021
Impfdatum
21.04.2021
Beginn
21.04.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient received an expired dose of TENIVAC/no AE; Initial information regarding an unsolicited valid non-serious case was received on 21-Apr-2021 from a health care professional via Medical Information (Reference number- 00571113) and transmitted to Sanofi on 21-Apr-2021. This case involves a 56 year-old female patient who was vaccinated with expired dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (Expired product administered). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) on 21-Apr-2021 for prophylactic vaccination. On 21-Apr-2021, the patient received 0.5 mL (total) dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (lot U6265AA and expiry date 19-Apr-2021) via an intramuscular route at the right deltoid for prophylactic vaccination. It was a case of actual medication error due to expired vaccine used (latency was on same day). At the time of report, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
SHINGRIX
Allergien
-
Vorherige Impfungen
-

VAERS 1299382

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
WA
Alter
-
Geschlecht
M
Eingang
08.05.2021
Impfdatum
23.04.2021
Beginn
23.04.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

A patient received an expired vaccine, no AE; Initial information regarding an unsolicited valid non-serious case was received from other healthcare professional (Reference number- 00575182) and transmitted to Sanofi on 23-Apr-2021. This case involves a male patient (age not reported) who received a 0.5 mL dose of expired DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (lot U6265AA and expiry date: 19-Apr-2021) via an unknown route in the deltoid for prophylactic vaccination on 23-Apr-2021 (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided. The patient did not receive any other medications or vaccinations at the time of reporting. This was a case of actual medication error case due to expired vaccine used (latency same day). At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1296269

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
NE
Alter
59,0
Geschlecht
F
Eingang
07.05.2021
Impfdatum
04.05.2021
Beginn
07.05.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event Product storage error

Symptomtext

No adverse reaction is noted. Patient was given vaccine that was past expiration date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1294209

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
NC
Alter
29,0
Geschlecht
F
Eingang
06.05.2021
Impfdatum
26.04.2021
Beginn
26.04.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

29 year old female patient was administered expired dose of TENIVAC, with no adverse event; Initial information received on 27-Apr-2021 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 29 year old female patient who was administered expired dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (expired product administered). Medical history, medical treatment, vaccination, concomitant medication and family history were not provided. On 26-Apr-2021, the patient received a 0.5 ml booster dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (lot U6265AA and expiry date: 19-Apr-2021) (Frequency: Once) via an intramuscular route at an the deltoid NOS (not otherwise specified) for prophylactic vaccination. It was a case of actual medication error due to expired vaccine used (latency on same day). It was also reported that this case was placed in proxy as there was no one available during the time of the attempted transfer. A call back is needed for assistance. The caller stated that her previous call was disconnected and is calling back because she wanted to know if there is any data supporting the use of expired TENIVAC. The caller stated that the product expired last week and was administered today. The caller would like to know if the patient must be revaccinated. The TENIVAC was given in the deltoid, but they not sure if it was left or right deltoid. No further information was provided. At the time of report no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1294207

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
NY
Alter
17,0
Geschlecht
M
Eingang
06.05.2021
Impfdatum
20.04.2021
Beginn
20.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patient inadvertently received an expired dose of TENIVAC with no reported adverse event; Initial information was received on 20-Apr-2021 regarding an unsolicited valid non-serious case from a nurse. This case involves a 17-year-old male patient who inadvertently received an expired dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (expired product administered). Medical history, medical treatment(s) and family history were not provided. The patient's past vaccination(s) included DIPHTHERIA TETANUS ACELLULAR PERTUSSIS on 12-FEB-2021. Concomitant medications included POLIO VACCINE INACT 3V (VERO) (IPOL [POLIO VACCINE INACT 3V (VERO)]) for Immunisation; MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Immunisation; and HEPATITIS B VACCINE (HEPATITIS B VACCINE) for Immunisation. On 20-Apr-2021, the patient received a first dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (lot U6265AA, expiry date-19-Apr-2021) via an intramuscular route in the right deltoid for prophylactic vaccination. It was a case of actual medication error due to expired vaccine used (on the same day). At the time of report, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
IPOL [POLIO VACCINE INACT 3V (VERO)]; MMR; HEPATITIS B VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 1291337

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
OH
Alter
-
Geschlecht
F
Eingang
05.05.2021
Impfdatum
21.04.2021
Beginn
21.04.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient received an expired dose of TENIVAC with no adverse event; Initial information regarding an unsolicited valid non-serious case was received from other health professional (Reference number- 00572564) and transmitted to Sanofi on 22-Apr-2021. This case involves a female patient with age 65 or above who was administered with 0.5 mL expired dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (lot U6265AA and expiry date: 19-Apr-2021) via unknown route at an unknown administration site (expired product administered) for prophylactic vaccination on 21-Apr-2021. Medical history, past medical treatment(s), past vaccination(s), concomitant medication and family history were not provided. It was an actual medication error case due to expired vaccine used (latency: same day). The reporter wanted to know if there is a grace period? At the time of reporting, the patient experienced no specific adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1255781

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
PA
Alter
12,0
Geschlecht
M
Eingang
25.04.2021
Impfdatum
10.04.2021
Beginn
10.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

a 12 years old patient received TENIVAC instead of ADACEL/ No AE; Initial information received on 12-Apr-2021 regarding an unsolicited valid non-serious case received from a nurse via (Reference number: 00557053). This case involves a 12 years old male patient who received a 0.5 ml first dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] batch number: U6265AA, Frequency: once, Strength: Standard, Expiry date: 19-Apr-2021 via intramuscular route in the left deltoid on 10-Apr-2021 for prophylactic vaccination instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (wrong product administered). The patient's past vaccination included Diphtheria, Tetanus, and Acellular Pertussis (DTAP) for which patient had completed five doses. The patient's medical history, medical treatments and family history were not provided. Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL) for prophylactic vaccination. It was an actual medication error due to wrong vaccine administered (latency: same day). Potential Product Technique Complain: No. Caller with question on whether dose of ADACEL needs to be administered. At the time of report, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1248047

SANOFI PASTEUR · TD ADSORBED (TENIVAC) · Charge U6265AA

gering
Staat
NC
Alter
18,0
Geschlecht
F
Eingang
23.04.2021
Impfdatum
21.04.2021
Beginn
21.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Patient was given an expired Td dose. State consultant consulted and informed us to repeat the dose. We called and informed the parent and she voiced understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-